-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Coagulation/Platelet/Hemostasis

Program: Special-Interest Sessions
Session: American Board of Internal Medicine Maintenance of Certification Learning Session
Friday, December 4, 2015, 2:00 PM-5:00 PM
Regency Ballroom O-P (Hyatt Regency Orlando)

Alice D. Ma, MD

Hemophilia Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC

Disclosures: Ma: Baxalta: Membership on an entity’s Board of Directors or advisory committees , Research Funding ; Biogen Idec: Membership on an entity’s Board of Directors or advisory committees , Research Funding ; Kedrion: Membership on an entity’s Board of Directors or advisory committees ; Novo Nordisk: Membership on an entity’s Board of Directors or advisory committees ; Bayer: Membership on an entity’s Board of Directors or advisory committees . Off Label Use: recombinant VWF and plasma-derived VWF for treatment of menorrhagia in VWD.

See more of: American Board of Internal Medicine Maintenance of Certification Learning Session
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>